General Information of the Compound
| Compound ID |
CP0502895
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-2-(2-(2-(2-acetamido-N-benzylacetamido)-N-benzylacetamido)acetamido)-N-((S)-1-(2-amino-2-oxoethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-5-guanidinopentanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H51N11O7
|
||||||||||||||||||
| Molecular Weight |
809.929
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)NCC(=O)N(CC(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(N)=O)Cc1ccccc1)Cc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H51N11O7/c1-27(53)46-22-37(56)52(24-29-13-6-3-7-14-29)26-38(57)51(23-28-11-4-2-5-12-28)25-36(55)49-33(17-10-18-45-41(43)44)40(59)50-34(39(58)48-21-35(42)54)19-30-20-47-32-16-9-8-15-31(30)32/h2-9,11-16,20,33-34,47H,10,17-19,21-26H2,1H3,(H2,42,54)(H,46,53)(H,48,58)(H,49,55)(H,50,59)(H4,43,44,45)/t33-,34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UENCACMFJICPLI-HEVIKAOCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01431, Melanocortin receptor 4
Protein ID: PT01528, Melanocortin receptor 5
Protein ID: PT01440, Melanocyte-stimulating hormone receptor